Although glucosuria is connected with polyuria, polydipsia, nocturnal enuresis, and polyphagia, serious complications such as ascending urinary tract infections or impaired kidney function are rarely observed in individuals with SGLT2 gene mutation, indicating that SGLT2 inhibitors could be developed as safe glucose-lowering drugs (40). This evidence concerns the gene SLC5A2 and Glycosuria.